A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

NCT06066346 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Talquetamab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]